Status
Global HQ
Cambridge, United States
Countries of investment
Investment stages
Industries
About
MDBio Ventures, the investment arm of MD Biosciences, leverages over 30 years of expertise in early-stage drug and device development to identify and support promising innovations. Specializing in Seed and Series A funding, MDBio Ventures is dedicated to advancing companies within the pharmaceutical, diagnostic, and medical device sectors. Their strategic investments aim to accelerate the growth of cutting-edge technologies that have the potential to transform healthcare and improve patient outcomes. By fostering collaboration and innovation, MDBio Ventures plays a pivotal role in shaping the future of biomedicine.
MDBio Ventures, the investment arm of MD Biosciences, leverages over 30 years of expertise in early-stage drug and device development to identify and support promising innovations. Specializing in Seed and Series A funding, MDBio Ventures is dedicated to advancing companies within the pharmaceutical, diagnostic, and medical device sectors. Their strategic investments aim to accelerate the growth of cutting-edge technologies that have the potential to transform healthcare and improve patient outcomes. By fostering collaboration and innovation, MDBio Ventures plays a pivotal role in shaping the future of biomedicine.
Investment Thesis
Manager's Experience
With extensive experience in the biotechnology and healthcare sectors, the fund manager has successfully led numerous investments in early and growth-stage companies. Active primarily in North America and Europe, they have executed over 30 deals, resulting in several notable exits that underscore a strategic, data-driven investment approach. Their focus on innovative companies demonstrates a commitment to advancing transformative solutions while leveraging operational insights to drive value creation. The emphasis on thematic investing in cutting-edge technologies positions the fund manager as a key player in the evolving landscape of life sciences.